Oral mucositis: the hidden side of cancer therapy
Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …
Photobiomodulation—underlying mechanism and clinical applications
C Dompe, L Moncrieff, J Matys… - Journal of clinical …, 2020 - mdpi.com
The purpose of this study is to explore the possibilities for the application of laser therapy in
medicine and dentistry by analyzing lasers' underlying mechanism of action on different …
medicine and dentistry by analyzing lasers' underlying mechanism of action on different …
Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology
DG Pfister, S Spencer, D Adelstein, D Adkins… - Journal of the National …, 2020 - jnccn.org
Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …
Gut microbiota and cancer: from pathogenesis to therapy
S Vivarelli, R Salemi, S Candido, L Falzone… - Cancers, 2019 - mdpi.com
Cancer is a multifactorial pathology and it represents the second leading cause of death
worldwide. In the recent years, numerous studies highlighted the dual role of the gut …
worldwide. In the recent years, numerous studies highlighted the dual role of the gut …
The gut microbiome: what the oncologist ought to know
KA Lee, MK Luong, H Shaw, P Nathan… - British journal of …, 2021 - nature.com
The gut microbiome (GM) has been implicated in a vast number of human pathologies and
has become a focus of oncology research over the past 5 years. The normal gut microbiota …
has become a focus of oncology research over the past 5 years. The normal gut microbiota …
Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics
FM de Man, AKL Goey, RHN van Schaik… - Clinical …, 2018 - Springer
Since its clinical introduction in 1998, the topoisomerase I inhibitor irinotecan has been
widely used in the treatment of solid tumors, including colorectal, pancreatic, and lung …
widely used in the treatment of solid tumors, including colorectal, pancreatic, and lung …
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
J Robijns, RG Nair, J Lodewijckx, P Arany… - Frontiers in …, 2022 - frontiersin.org
Disclaimer This article is based on recommendations from the 12th WALT Congress, Nice,
October 3-6, 2018, and a follow-up review of the existing data and the clinical observations …
October 3-6, 2018, and a follow-up review of the existing data and the clinical observations …
Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal …
HY Sroussi, JB Epstein, RJ Bensadoun… - Cancer …, 2017 - Wiley Online Library
Patients undergoing radiation therapy for the head and neck are susceptible to a significant
and often abrupt deterioration in their oral health. The oral morbidities of radiation therapy …
and often abrupt deterioration in their oral health. The oral morbidities of radiation therapy …
Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …
revolutionized the management of acid-related diseases. Studies in primary care and …
Mitigating acute chemotherapy-associated adverse events in patients with cancer
NM Kuderer, A Desai, MB Lustberg… - Nature Reviews Clinical …, 2022 - nature.com
Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …